MENU

MRNS Marinus Pharmaceuticals Forecast, Technical & Fundamental Analysis

a developer of innovative neuropsychiatric therapeutics

Industry Biotechnology
MRNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
MRNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

MRNS is expected to report earnings to fall 30.48% to -29 cents per share on March 11

Marinus Pharmaceuticals MRNS Stock Earnings Reports
Q4'24
Est.
$-0.29
Q3'24
Missed
by $0.01
Q2'24
Missed
by $0.04
Q1'24
Missed
by $0.03
Q4'23
Missed
by $0.12
The last earnings report on November 12 showed earnings per share of -41 cents, missing the estimate of -40 cents. With 3.77M shares outstanding, the current market capitalization sits at 13.66M.
A.I. Advisor
published General Information

General Information

a developer of innovative neuropsychiatric therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
100 Matsonford Road
Phone
+1 484 801-4670
Employees
165
Web
https://www.marinuspharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

MRNS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MRNS has been loosely correlated with NTLA. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if MRNS jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRNS
1D Price
Change %
MRNS100%
-0.28%
NTLA - MRNS
38%
Loosely correlated
-1.87%
CLDI - MRNS
38%
Loosely correlated
-1.14%
FOLD - MRNS
36%
Loosely correlated
-0.10%
XERS - MRNS
34%
Loosely correlated
+1.19%
SAGE - MRNS
32%
Poorly correlated
-1.40%
More